Table 2.
Drugs Taken at 1.5 Years by Those Available at Follow-Up by Original Treatment Assignment and by Whether They Received Parent Training
| Total | Drug combinations by 4 treatment groups | Parent training | |||||
|---|---|---|---|---|---|---|---|
| Drug | (N = 93)a n (%) | ATX+PT (N = 25)a n (%) | ATX (N = 27) n (%) | PT+placebo (N = 19) n (%) | Placebo (N = 22) n (%) | Yes (N = 44)a n (%) | No (N = 49) n (%) |
| No medications | 23 (24.7) | 3 (12.0) | 7 (25.9) | 5 (26.3) | 8 (36.4) | 8 (18.2) | 15 (30.6) |
| Atomoxetine only | 24 (25.8) | 6 (24.0) | 11 (40.7) | 4 (21.1) | 3 (13.6) | 10 (22.7) | 14 (28.6) |
| ATX+another drug | 8 (8.6) | 2 (8.0) | 0 (0.0) | 4 (21.1) | 2 (9.1) | 6 (13.6) | 2 (4.1) |
| Stimulant only | 13 (14.0) | 4 (16.0) | 5 (18.5) | 3 (15.8) | 1 (4.5) | 7 (15.9) | 6 (12.2) |
| Stimulant+any non-ATX drug | 8 (8.6) | 6 (24.0) | 1 (3.7) | 0 (0.0) | 1 (4.5) | 6 (13.6) | 2 (4.1) |
| Other drugs and combinations | 17 (18.3) | 4 (16.0) | 3 (11.1) | 3 (15.8) | 7 (31.8) | 7 (15.9) | 10 (20.4) |
| Same as week 34 end-of-study treatment | 45 (47.9) | 13 (52.0) | 14 (51.9) | 7 (35.0) | 11 (50) | 20 (44.4) | 25 (51) |
| Changed from week 34 to FU | 49 (52.1) | 12 (48.0) | 13 (48.1) | 13 (65.0) | 11 (50) | 25 (55.6) | 24 (49) |
No contrasts were statistically significant.
a
Marks one subject did not report their medications at 1-year FU. “Other Drugs” includes combinations of the following drugs not included in the table: alpha-2-adrenergic agonist, atypical antipsychotics, serotonin reuptake inhibitors, other non-ADHD medications, bupropion.
ATX, atomoxetine; FU, follow-up; PT, parent training.